AAAAAA

   
Results: 1-25 | 26-35 |
Results: 26-35/35

Authors: Bray, M
Citation: M. Bray, Handbook for treatment of attachment-trauma problems in children., CHILD ABUSE, 23(5), 1999, pp. 520-522

Authors: Dunbar, MR Velarde, R Gregg, MA Bray, M
Citation: Mr. Dunbar et al., Health evaluation of a pronghorn antelope population in Oregon, J WILDL DIS, 35(3), 1999, pp. 496-510

Authors: Schmaljohn, C Custer, D VanderZanden, L Spik, K Rossi, C Bray, M
Citation: C. Schmaljohn et al., Evaluation of tick-borne encephalitis DNA vaccines in monkeys, VIROLOGY, 263(1), 1999, pp. 166-174

Authors: Bray, M
Citation: M. Bray, Textures of light: Vision and touch in Irigaray, Levinas and Merleau-Ponty, REV METAPHY, 53(1), 1999, pp. 204-205

Authors: Bray, M
Citation: M. Bray, Hegel, history, and interpretation, REV METAPHY, 52(3), 1999, pp. 679-680

Authors: Mosca, F Bray, M Colnaghi, MR Fumagalli, M Compagnoni, G
Citation: F. Mosca et al., Cerebral vasoreactivity to arterial carbon dioxide tension in preterm infants: The effect of ibuprofen, J PEDIAT, 135(5), 1999, pp. 644-646

Authors: Jahrling, PB Geisbert, TW Geisbert, JB Swearengen, JR Bray, M Jaax, NK Huggins, JW LeDuc, JW Peters, CJ
Citation: Pb. Jahrling et al., Evaluation of immune globulin and recombinant interferon-alpha 2b for treatment of experimental Ebola virus infections, J INFEC DIS, 179, 1999, pp. S224-S234

Authors: Huggins, J Zhang, ZX Bray, M
Citation: J. Huggins et al., Antiviral drug therapy of filovirus infections: S-adenosylhomocysteine hydrolase inhibitors inhibit Ebola virus in vitro and in a lethal mouse model, J INFEC DIS, 179, 1999, pp. S240-S247

Authors: Bray, M Davis, K Geisbert, T Schmaljohn, C Huggins, J
Citation: M. Bray et al., A mouse model for evaluation of prophylaxis and therapy of Ebola hemorrhagic fever, J INFEC DIS, 179, 1999, pp. S248-S258

Authors: Bray, M
Citation: M. Bray, Regional examinations councils and geopolitical change: Commonality, diversity, and lessons from experience, INT J ED D, 18(6), 1998, pp. 473-486
Risultati: 1-25 | 26-35 |